Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (201-210 of 270) with videos related to

Pageof 27
Sort By:
Journal of the National Cancer Institute|January 31, 2019
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune EvasionSabine Heitzeneder, Elena Sotillo, Jack F Shern, et al.
Molecular Cancer Therapeutics|August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder CancerYoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
Molecular Oncology|October 21, 2019
The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancerThomas Kryza, Nathalie Bock, Scott Lovell, et al.
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2019
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate CancerElie Ritch, Simon Y F Fu, Cameron Herberts, et al.
Endocrine-Related Cancer|October 6, 2023
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cellsParvin Yenki, Satyam Bhasin, Liang Liu, et al.
Oncogene|September 9, 2018
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Oncotarget|December 10, 2015
Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolismPeder Rustøen Braadland, Helene Hartvedt Grytli, Håkon Ramberg, et al.
Oncotarget|February 22, 2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancerDebashis Sahoo, Wei Wei, Heidi Auman, et al.
Cancer Discovery|October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerJennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.
Pageof 27

Showing results (201-210 of 270) with videos related to

Sort By:
Pageof 27
Journal of the National Cancer Institute|January 31, 2019
Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune EvasionSabine Heitzeneder, Elena Sotillo, Jack F Shern, et al.
Molecular Cancer Therapeutics|August 28, 2020
Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder CancerYoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, et al.
Molecular Oncology|October 21, 2019
The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancerThomas Kryza, Nathalie Bock, Scott Lovell, et al.
Oncogene|August 15, 2019
Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancerSubing Cao, Tianfang Ma, Nathan Ungerleider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2019
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate CancerElie Ritch, Simon Y F Fu, Cameron Herberts, et al.
Endocrine-Related Cancer|October 6, 2023
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cellsParvin Yenki, Satyam Bhasin, Liang Liu, et al.
Oncogene|September 9, 2018
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcomeNataly Stylianou, Melanie L Lehman, Chenwei Wang, et al.
Oncotarget|December 10, 2015
Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolismPeder Rustøen Braadland, Helene Hartvedt Grytli, Håkon Ramberg, et al.
Oncotarget|February 22, 2018
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancerDebashis Sahoo, Wei Wei, Heidi Auman, et al.
Cancer Discovery|October 28, 2016
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate CancerJennifer L Bishop, Daksh Thaper, Sepideh Vahid, et al.
Pageof 27